Back to Screener

Healthcare

Biodesix, Inc.(BDSX)

Live Price

Offline

$23.34

+16.47% today

1Y Change

+255.32%

Window

Jun 30, 2025 โ†’ Jun 25, 2026

Market Cap
$110.00M
Revenue Growth
+24.1%
EPS Growth
+29.2%
Dividend Yield
0.0%

Coverage: 248 bars ยท Jun 30, 2025 โ†’ Jun 25, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Biodesix, Inc. (BDSX) is a Healthcare stock with a market cap of $110.00M. The stock last traded around $23.34 and up 255.3% across the available one-year price window (Jun 30, 2025 โ†’ Jun 25, 2026). Baseline metrics include revenue growth of +24.1%, EPS growth of +29.2%, a dividend yield of 0.0%. What stands out right now is revenue +24.1%, EPS +29.2%, free cash flow +54.6% with operating margin -26.0% and ROIC -30.6%. Valuation is more restrained than many high-expectation growth names at price/sales 1.2. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines BDSX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

BDSX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

Mixed setup vs SPY

BDSX is 236.47 pts ahead over the shared 1Y window.

BDSX had 40.15 pts deeper max drawdown than SPY.

BDSX beat SPY in 2 of 2 calendar years shown and trailed in 0.

BDSX

+255.32%

Normalized return

SPY

+18.85%

S&P 500

Excess Return

+236.47 pts

Relative to SPY

BDSX Max Drawdown

-49.28%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

BDSXSPY

Calendar-Year Returns

Uses the longest available daily history for BDSX and SPY.

YearBDSXSPYExcessLeader
2026+210.22%+6.71%+203.51 ptsBDSX
2025+19.15%+11.19%+7.96 ptsBDSX

Earnings Reports

๐Ÿ“… Last reportedMay 12, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 12, 26
โ€”
Est -1.08
โ€”
โ€”
Est 23027.6B
โ€”
May 12
โ€”
Feb 26, 26
โœ“
-0.49
Est -1.05
+53.3%
28755.0B
Est 25727.7B
+11.8%
Feb 26
โ€”
Nov 3, 25
โœ“
-1.16
Est -1.60
+27.5%
21768.0B
Est 26250.0B
-17.1%
Nov 3
โ€”
Aug 7, 25
โœ—
-1.60
Est -1.40
-14.3%
20018.0B
Est 18466.7B
+8.4%
Aug 7
โ€”
May 13, 25
โ€”
-0.08
Est -0.08
0.0%
17958.0B
Est 22566.7B
-20.4%
May 13
โ€”
Mar 3, 25
โœ“
-0.06
Est -0.07
+14.3%
20429.0B
Est 20320.0B
+0.5%
Mar 3
โ€”
Nov 1, 24
โœ“
-0.07
Est -0.08
+12.5%
18151.0B
Est 19833.3B
-8.5%
Nov 1
โ€”
Aug 7, 24
โœ“
-0.08
Est -0.09
+11.1%
17925.0B
Est 16210.0B
+10.6%
Aug 7
โ€”
May 8, 24
โœ“
-0.14
Est -0.15
+6.7%
14818.0B
Est 14180.0B
+4.5%
May 8
โ€”
Mar 1, 24
โœ“
-0.10
Est -0.11
+9.1%
14668.0B
Est 15610.0B
-6.0%
Mar 1
โ€”
Nov 7, 23
โœ“
-0.12
Est -0.15
+20.0%
13491.0B
Est 15600.0B
-13.5%
Nov 7
โ€”
Aug 7, 23
โœ“
-0.17
Est -0.21
+19.1%
11872.0B
Est 11670.0B
+1.7%
Aug 7
โ€”
May 11, 23
โœ“
-0.24
Est -0.26
+7.7%
9056.0B
Est 8700.0B
+4.1%
May 11
โ€”
Mar 6, 23
โœ—
-0.28
Est -0.26
-7.7%
9608.0B
Est 10771.3B
-10.8%
Mar 6
โ€”
Nov 3, 22
โœ—
-0.34
Est -0.32
-6.3%
11107.0B
Est 10154.5B
+9.4%
Nov 3
โ€”
Aug 4, 22
โœ“
-0.40
Est -0.47
+14.9%
10950.0B
Est 8825.3B
+24.1%
Aug 4
โ€”
May 11, 22
โœ—
-0.50
Est -0.38
-31.6%
6548.0B
Est 6466.7B
+1.3%
May 11
โ€”
Mar 14, 22
โœ“
-0.49
Est -0.50
+2.0%
7224.0B
Est 7288.3B
-0.9%
Mar 14
โ€”
Nov 15, 21
โ€”
-0.50
Est -0.50
0.0%
6531.0B
Est 7530.0B
-13.3%
Nov 15
โ€”
Aug 10, 21
โœ—
-0.41
Est -0.31
-32.3%
11885.0B
Est 21140.0B
-43.8%
Aug 10
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar